MedTrace Logo

Assessing the Effects of HbA1c Reduction on Alleviating Nonspecific Back Pain

NCT06064058 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2023-10-05

No results posted yet for this study

Summary

Prediabetes, characterized by elevated HbA1c levels, is a common precursor to type 2 diabetes mellitus. Recent studies have suggested a potential link between prediabetes and nonspecific back pain. This randomized controlled trial aimed to assess whether reducing HbA1c levels through lifestyle interventions and, along with the correction of vitamin D and magnesium, can alleviate nonspecific back pain in prediabetic patients.

Conditions

Interventions

DIETARY_SUPPLEMENT

Ghazwan program

6-month lifestyle modification program, focusing on diet, sleep, exercise, and vitamin D and magnesium correction.

DRUG

Standard management

Standard care with NSAIDs and acetaminophen for pain management

Sponsors & Collaborators

  • University of Baghdad

    lead OTHER

Principal Investigators

  • Hashim T Hashim, MBChB · University of Warith Al-Anbiyaa, College of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-30
Primary Completion
2023-08-30
Completion
2023-09-01

Countries

  • Iraq

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06064058 on ClinicalTrials.gov